Key Events This Week
7 Sep: Intraday high surge to Rs.441.85 (+7.03%)
8 Sep: New intraday high at Rs.457.45 with 8.93% gain
9 Sep: Technical momentum shift amid strong price gains
10 Sep: Technical momentum signals bullish outlook despite price dip
11 Sep: Week closes at Rs.423.35, up 2.82% vs Sensex down 1.68%
7 September: Strong Intraday Surge Amid Market Weakness
Gujarat Themis Biosyn Ltd began the week with a robust performance, surging 7.03% to close at Rs.429.65, supported by an intraday high of Rs.441.85. This gain significantly outpaced the Sensex, which declined 0.46% to 36,218.97. The stock’s rally was underpinned by its trading above all major moving averages (5, 20, 50, 100, and 200 days), signalling strong technical momentum. This outperformance was notable given the broader market’s bearish tone, with the Sensex trading below key moving averages and signalling a downtrend.
8 September: New Intraday High and Technical Upgrades
The momentum continued on 8 September as Gujarat Themis Biosyn Ltd surged 8.93% to Rs.453.10, reaching an intraday peak of Rs.457.45. This marked a two-day cumulative gain of over 11%, with the stock closing just 4.81% below its 52-week high of Rs.479.45. Despite the Sensex falling 0.21% to 36,144.32, the stock’s resilience was supported by bullish MACD and Bollinger Bands on weekly and monthly charts, alongside a Mojo Score upgrade to 57.0 and a Hold rating. However, some oscillators like KST and OBV suggested caution, reflecting mixed momentum signals.
This week's disclosed pick, a Large Cap from NBFC, comes with precise Target Price and analysis. Check if you're positioned right for this opportunity!
- - Precise target price set
- - Weekly selection live
- - Position check opportunity
9 September: Technical Momentum Shift Amid Price Gains
On 9 September, the stock experienced a technical momentum shift, closing at Rs.431.30, down 4.81% from the previous day’s close but still reflecting a strong weekly trend. Intraday volatility was high, with a range between Rs.427.55 and Rs.463.00. The Mojo Grade remained at Hold with a score of 50.0, reflecting cautious optimism. While daily moving averages stayed bullish, the RSI was bearish on the weekly timeframe, and the KST oscillator remained mildly bearish, indicating potential short-term consolidation. The Sensex declined 0.62% to 35,921.77, underscoring the stock’s relative strength despite the dip.
10 September: Bullish Technical Outlook Despite Price Pullback
The stock closed marginally lower at Rs.430.80 (-0.12%) on 10 September, amid a broader market decline of 0.03%. Technical indicators showed a shift from mildly bullish to bullish, supported by positive MACD and Bollinger Bands on weekly and monthly charts. Daily moving averages confirmed short-term strength, while RSI remained neutral, suggesting room for further gains without immediate overbought risk. However, the KST oscillator and Dow Theory assessments remained mildly bearish or tentative, and On-Balance Volume showed mixed signals, indicating that volume support for the rally was not yet fully established.
Considering Gujarat Themis Biosyn Ltd? Wait! SwitchER has found potentially better options in and beyond. Compare this small-cap with top-rated alternatives now!
- - Better options discovered
- - + beyond scope
- - Top-rated alternatives ready
11 September: Week Closes with Modest Gain Amid Market Weakness
The week concluded on 11 September with Gujarat Themis Biosyn Ltd closing at Rs.423.35, down 1.73% on the day but still posting a weekly gain of 2.82%. The Sensex fell 0.39% to 35,773.24, extending its three-week decline. The stock’s ability to outperform the benchmark by over 4.5% for the week highlights its relative strength. Technical indicators remain cautiously optimistic, with the Mojo Score steady at 57.0 and the Hold rating intact. The stock continues to trade well above its 52-week low of Rs.225.75, maintaining a strong recovery trajectory despite recent volatility.
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-09-07 | Rs.429.65 | +4.35% | 36,218.97 | -0.46% |
| 2026-09-08 | Rs.453.10 | +5.46% | 36,144.32 | -0.21% |
| 2026-09-09 | Rs.431.30 | -4.81% | 35,921.77 | -0.62% |
| 2026-09-10 | Rs.430.80 | -0.12% | 35,912.77 | -0.03% |
| 2026-09-11 | Rs.423.35 | -1.73% | 35,773.24 | -0.39% |
Key Takeaways
Outperformance Amid Market Weakness: Gujarat Themis Biosyn Ltd outpaced the Sensex by 4.5% during the week, closing at Rs.423.35 (+2.82%) versus the Sensex’s 1.68% decline. This highlights the stock’s resilience and relative strength in a bearish market environment.
Strong Early-Week Momentum: The stock’s intraday highs on 7 and 8 September (Rs.441.85 and Rs.457.45 respectively) demonstrated robust buying interest, supported by bullish technical indicators and trading above all major moving averages.
Technical Momentum Shifts: The week saw a transition from mildly bullish to bullish technical momentum, with MACD and Bollinger Bands signalling strength on weekly and monthly charts. However, mixed signals from RSI, KST, and OBV suggest caution and potential short-term consolidation.
Mojo Score and Rating Stability: The Mojo Score improved to 57.0 with a Hold rating, reflecting a stabilised outlook after prior downgrades. This rating aligns with the stock’s technical and price action profile during the week.
Volatility and Volume Nuances: Despite positive price moves, volume indicators such as OBV showed mixed trends, indicating that buying interest may not be fully sustained. Intraday volatility was notable, especially on 9 September, suggesting a consolidation phase within the broader uptrend.
Conclusion
Gujarat Themis Biosyn Ltd demonstrated commendable resilience during a challenging market week, delivering a 2.82% gain against a declining Sensex. Early-week rallies near 52-week highs underscored strong technical momentum, supported by bullish MACD and moving averages. However, mixed signals from momentum oscillators and volume indicators suggest that the stock is undergoing a consolidation phase, warranting cautious optimism. The Hold rating and Mojo Score of 57.0 reflect a balanced risk-reward profile. Investors should monitor key technical levels and volume trends closely to assess the sustainability of this momentum in the coming weeks, especially given the stock’s small-cap status and sector volatility.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
